What guidelines has EMA established for clinical trials involving neonates?
The EMA has established comprehensive guidelines for conducting clinical trials involving neonates to ensure their safety and well-being. These guidelines emphasize the ethical considerations, including obtaining informed consent from parents or guardians, and the scientific aspects, including appropriate study designs and endpoints. The guidelines also address specific challenges in neonatal trials, such as dosing and the selection of appropriate biomarkers.
